59 related articles for article (PubMed ID: 3630312)
21. [Abnormal coronary vasomotility in subjects with normal coronary arteries and reduced reserve of coronary flow].
Bortone A; Hess OM; Gaglione A; Locuratolo N; Musci S; Sebastiani M; Rizzon P; Chiddo A
Cardiologia; 1989 Jan; 34(1):33-46. PubMed ID: 2720712
[TBL] [Abstract][Full Text] [Related]
22. Effects of short-term administration of sublingual nifedipine on coronary arterial wall elastic properties: evaluation by intravascular ultrasound.
Mizushige K; DeMaria AN; Yoshikawa K; Yuba M; Morita H; Senda S; Matsuo H
J Cardiovasc Pharmacol; 1997 Apr; 29(4):508-14. PubMed ID: 9156361
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of the cardiodepressive effects of nifedipine, isradipine, nisoldipine and felodipine in patients with coronary heart disease].
Mauser M; Voelker W; Ickrath O; Karsch KR
Z Kardiol; 1993 Jan; 82(1):17-27. PubMed ID: 8470415
[TBL] [Abstract][Full Text] [Related]
24. [Effect of intracoronary nifedipine on coronary sinus blood flow and myocardial oxygen consumption in patients with coronary artery disease].
Schanzenbächer P; Liebau G; Deeg P; Kochsiek K
Z Kardiol; 1982 Jun; 71(6):393-7. PubMed ID: 7124058
[TBL] [Abstract][Full Text] [Related]
25. [Nifedipine level in the blood and its immediate hypotensive effect after its sublingual administration to aged patients].
Kawecka-Jaszcz K; Grodzicki T; Skoczeń M; Czarnecka D; Gryglewska B; Dubiel JP; Kocemba J; Witek J
Przegl Lek; 1989; 46(2):311-5. PubMed ID: 2772233
[TBL] [Abstract][Full Text] [Related]
26. The antiatherogenic effect of nifedipine on intramural small coronary arterial lesions in cholesterol-fed rabbits.
Kato H; Okada R; Enoki M; Oogushi K; Emura S; Takashima T; Ohmori K
Angiology; 1998 Jan; 49(1):49-54. PubMed ID: 9456164
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
[TBL] [Abstract][Full Text] [Related]
28. Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.
Takahashi T; Takahashi K; Kishi-Tanikawa S; Tsuchida K; Araki H; Higuchi S
J Pharmacol Exp Ther; 1996 Sep; 278(3):1028-33. PubMed ID: 8819482
[TBL] [Abstract][Full Text] [Related]
29. Active and passive coronary vasodilation after intracoronary and sublingual nitroglycerin.
Schulz W; von Anderten W; Reiber JH; Bernauer R; Kaltenbach M; Kober G
Z Kardiol; 1983; 72 Suppl 3():82-6. PubMed ID: 6421018
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of nifedipine on regional myocardial blood flow in patients with coronary artery disease.
Malacoff RF; Lorell BH; Mudge GH; Holman BL; Idoine J; Bifolck L; Cohn PF
Circulation; 1982 Jan; 65(1 Pt 2):I32-7. PubMed ID: 7053296
[TBL] [Abstract][Full Text] [Related]
31. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine.
Kaufmann P; Vassalli G; Utzinger U; Hess OM
J Am Coll Cardiol; 1995 Sep; 26(3):624-31. PubMed ID: 7642851
[TBL] [Abstract][Full Text] [Related]
32. Multislice CT coronary angiography: effect of sublingual nitroglycerine on the diameter of coronary arteries.
Dewey M; Hoffmann H; Hamm B
Rofo; 2006 Jun; 178(6):600-4. PubMed ID: 16703495
[TBL] [Abstract][Full Text] [Related]
33. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
34. Vasodilatory effects of nisoldipine on coronary arteries--correlation with plasma levels.
Jost S; Rafflenbeul W; Mogwitz B; Gulba D; Hecker H; Lichtlen PR
Cardiovasc Drugs Ther; 1990 Feb; 4(1):273-9. PubMed ID: 2285621
[TBL] [Abstract][Full Text] [Related]
35. Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure.
van Bortel L; Böhm R; Mooij J; Schiffers P; Rahn KH
Eur J Clin Pharmacol; 1989; 37(2):185-9. PubMed ID: 2792174
[TBL] [Abstract][Full Text] [Related]
36. Sublingual nifedipine: the continuing controversy.
Oliver S
Aust Crit Care; 1994 Jun; 7(2):12-4. PubMed ID: 8061479
[TBL] [Abstract][Full Text] [Related]
37. Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration.
Kleinbloesem CH; van Harten J; Wilson JP; Danhof M; van Brummelen P; Breimer DD
Clin Pharmacol Ther; 1986 Jul; 40(1):21-8. PubMed ID: 3720176
[TBL] [Abstract][Full Text] [Related]
38. Negligible sublingual absorption of nifedipine.
van Harten J; Burggraaf K; Danhof M; van Brummelen P; Breimer DD
Lancet; 1987 Dec; 2(8572):1363-5. PubMed ID: 2890954
[TBL] [Abstract][Full Text] [Related]
39. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.
Lichtlen PR; Hugenholtz PG; Rafflenbeul W; Hecker H; Jost S; Deckers JW
Lancet; 1990 May; 335(8698):1109-13. PubMed ID: 1971861
[TBL] [Abstract][Full Text] [Related]
40. Discrepancy between Bioavailability and Hypotensive Effect of Oral and Sublingual Nifedipine.
Palma-Aguirre JA; Montoya-Cabrera MA; du Souich P; Hoyo-Vadillo C; Flores-Murrieta FJ; Castañeda-Hernández G
Am J Ther; 1995 Jan; 2(1):3-9. PubMed ID: 11850640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
